ProPhase Labs to Present at the Access to Giving Virtual Investor Conference on July 15, 2021
July 12 2021 - 8:30AM
ProPhase Labs, Inc. (Nasdaq: PRPH) (“ProPhase” or the “Company”), a
diversified medical science and technology company, today announced
that Chief Executive Officer Ted Karkus will present a corporate
overview at the Access to Giving Virtual Investor Conference being
held on July 13 - 15, 2021.
Mr. Karkus will deliver his corporate
presentation on July 15 at 9:30am ET. Management will be available
for one-on-one meetings to be held throughout the conference.
To receive additional information, request an
invitation or to schedule a one-on-one meeting, please email
angie.goertz@issuerdirect.com.
Investors can register here.
About ProPhase Labs
ProPhase Labs, Inc. (Nasdaq: PRPH) is a
diversified medical science and technology company. The Company’s
subsidiary, ProPhase Diagnostics, offers a broad array of clinical
diagnostic insights and testing services at its CLIA certified
laboratories. ProPhase Diagnostics serves patients with SARS-CoV-2
(COVID-19) through both saliva and nasal swab methods. Our
methodology also has the capability to identify the possibility of
mutations. Critical to COVID testing, results are provided in under
24 hours. ProPhase also offers PCR (polymerase chain reaction)
testing for Influenzas A and B and RSV. ProPhase Diagnostics now
offers antigen and antibody/immunity tests in partnership with
scientists to broaden its COVID-19 testing beyond RT-PCR testing.
ProPhase Labs researches, develops, manufactures, distributes,
markets, and sells OTC consumer healthcare products and dietary
supplements, including dietary supplements under the TK
Supplements® brand. ProPhase actively pursues strategic
investments and acquisition opportunities for other companies,
technologies, and products. For more information,
visit www.ProPhaseLabs.com.
Contact:CORE IRJules
Abraham917-885-7378julesa@coreir.com
ProPhase Labs (NASDAQ:PRPH)
Historical Stock Chart
From Mar 2024 to Apr 2024
ProPhase Labs (NASDAQ:PRPH)
Historical Stock Chart
From Apr 2023 to Apr 2024